US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist
  • 2.240
  • -0.280-11.11%
Close Mar 28 16:00 ET
  • 2.330
  • +0.090+4.02%
Post 20:01 ET
70.23MMarket Cap-0.94P/E (TTM)

Acrivon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
40.82%179.48M
40.82%179.48M
31.93%187.45M
19.60%180.54M
-8.52%109.98M
-0.23%127.46M
-0.23%127.46M
84.96%142.09M
80.01%150.95M
--120.21M
-Cash and cash equivalents
10.56%39.82M
10.56%39.82M
45.40%43.42M
20.83%46.01M
-10.48%24.61M
22.01%36.02M
22.01%36.02M
-6.92%29.86M
-54.60%38.07M
--27.49M
-Short-term investments
52.73%139.66M
52.73%139.66M
28.34%144.04M
19.18%134.53M
-7.93%85.37M
-6.91%91.44M
-6.91%91.44M
150.83%112.23M
--112.88M
--92.72M
Other current assets
-3.80%2.15M
-3.80%2.15M
-36.26%1.53M
-21.78%1.82M
-42.20%2.17M
-48.57%2.23M
-48.57%2.23M
29.91%2.4M
-29.48%2.33M
--3.75M
Total current assets
40.05%181.63M
40.05%181.63M
30.79%188.98M
18.97%182.36M
-9.54%112.14M
-1.82%129.69M
-1.82%129.69M
83.66%144.49M
75.86%153.28M
--123.96M
Non current assets
Net PPE
1.48%8.03M
1.48%8.03M
36.81%8.47M
17.05%7.44M
15.86%7.61M
15.24%7.91M
15.24%7.91M
-12.94%6.19M
-11.95%6.36M
--6.57M
-Gross PPE
12.67%9.99M
12.67%9.99M
44.74%10.13M
25.85%8.85M
23.57%8.79M
21.72%8.86M
21.72%8.86M
-5.51%7M
-4.97%7.03M
--7.12M
-Accumulated depreciation
-105.23%-1.96M
-105.23%-1.96M
-105.58%-1.66M
-108.90%-1.41M
-116.51%-1.18M
-127.62%-956K
-127.62%-956K
-173.56%-807K
-276.54%-674K
---545K
Investments and advances
--5.09M
--5.09M
--15.39M
--39.9M
----
--0
--0
--0
--0
--39.28M
Non current deferred assets
556.18%1.65M
556.18%1.65M
--468K
--468K
--348K
--251K
--251K
----
----
----
Other non current assets
-52.17%198K
-52.17%198K
234.55%1.38M
3.19%421K
7.47%417K
6.70%414K
6.70%414K
5.93%411K
5.15%408K
--388K
Total non current assets
74.49%14.96M
74.49%14.96M
289.39%25.7M
612.68%48.23M
-81.88%8.38M
-82.55%8.57M
-82.55%8.57M
-27.00%6.6M
-13.62%6.77M
--46.23M
Total assets
42.18%196.59M
42.18%196.59M
42.09%214.68M
44.07%230.59M
-29.19%120.52M
-23.71%138.27M
-23.71%138.27M
72.26%151.09M
68.48%160.05M
--170.2M
Liabilities
Current liabilities
Payables
-84.98%758K
-84.98%758K
0.13%1.51M
-0.47%1.26M
49.64%2.06M
458.41%5.05M
458.41%5.05M
-23.89%1.5M
-33.39%1.27M
--1.37M
-accounts payable
-84.98%758K
-84.98%758K
0.13%1.51M
-0.47%1.26M
49.64%2.06M
458.41%5.05M
458.41%5.05M
-23.89%1.5M
-33.39%1.27M
--1.37M
Current accrued expenses
182.63%9.94M
182.63%9.94M
105.36%8.24M
107.77%6.1M
91.47%4.13M
63.25%3.52M
63.25%3.52M
67.24%4.01M
204.78%2.94M
--2.16M
Current debt and capital lease obligation
20.52%1.06M
20.52%1.06M
34.02%1.04M
29.88%978K
27.57%944K
20.80%877K
20.80%877K
8.23%776K
6.66%753K
--740K
-Current capital lease obligation
20.52%1.06M
20.52%1.06M
34.02%1.04M
29.88%978K
27.57%944K
20.80%877K
20.80%877K
8.23%776K
6.66%753K
--740K
Current deferred liabilities
----
----
----
----
----
----
----
--0
--0
--0
Current liabilities
29.40%17.21M
29.40%17.21M
59.36%14.82M
60.81%11.28M
59.12%9.04M
104.16%13.3M
104.16%13.3M
45.50%9.3M
57.61%7.02M
--5.68M
Non current liabilities
Long term debt and capital lease obligation
-31.30%2.59M
-31.30%2.59M
-18.41%2.97M
-15.72%3.24M
-13.47%3.5M
-11.05%3.77M
-11.05%3.77M
-17.56%3.64M
-16.38%3.85M
--4.05M
-Long term capital lease obligation
-31.30%2.59M
-31.30%2.59M
-18.41%2.97M
-15.72%3.24M
-13.47%3.5M
-11.05%3.77M
-11.05%3.77M
-17.56%3.64M
-16.38%3.85M
--4.05M
Total non current liabilities
-31.30%2.59M
-31.30%2.59M
-18.41%2.97M
-15.72%3.24M
-13.47%3.5M
-11.05%3.77M
-11.05%3.77M
-97.13%3.64M
-96.97%3.85M
--4.05M
Total liabilities
16.00%19.8M
16.00%19.8M
37.46%17.79M
33.70%14.53M
28.93%12.54M
58.78%17.07M
58.78%17.07M
-90.29%12.94M
-91.74%10.87M
--9.73M
Shareholders'equity
Share capital
34.78%31K
34.78%31K
40.91%31K
40.91%31K
4.55%23K
4.55%23K
4.55%23K
1,000.00%22K
1,000.00%22K
--22K
-common stock
34.78%31K
34.78%31K
40.91%31K
40.91%31K
4.55%23K
4.55%23K
4.55%23K
1,000.00%22K
1,000.00%22K
--22K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-69.19%-196.98M
-69.19%-196.98M
-79.22%-174.15M
-83.43%-151.7M
-93.21%-132.91M
-107.77%-116.42M
-107.77%-116.42M
-106.29%-97.17M
-118.18%-82.7M
---68.79M
Paid-in capital
57.06%373.28M
57.06%373.28M
57.14%370.22M
58.31%367.75M
5.11%240.93M
4.90%237.68M
4.90%237.68M
14,461.00%235.6M
17,404.97%232.29M
--229.23M
Gains losses not affecting retained earnings
638.55%447K
638.55%447K
358.94%782K
95.55%-19K
-877.78%-70K
12.63%-83K
12.63%-83K
-127.07%-302K
---427K
--9K
Total stockholders'equity
45.87%176.79M
45.87%176.79M
42.52%196.89M
44.83%216.06M
-32.71%107.98M
-28.91%121.2M
-28.91%121.2M
402.85%138.15M
507.87%149.18M
--160.47M
Total equity
45.87%176.79M
45.87%176.79M
42.52%196.89M
44.83%216.06M
-32.71%107.98M
-28.91%121.2M
-28.91%121.2M
402.85%138.15M
507.87%149.18M
--160.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 40.82%179.48M40.82%179.48M31.93%187.45M19.60%180.54M-8.52%109.98M-0.23%127.46M-0.23%127.46M84.96%142.09M80.01%150.95M--120.21M
-Cash and cash equivalents 10.56%39.82M10.56%39.82M45.40%43.42M20.83%46.01M-10.48%24.61M22.01%36.02M22.01%36.02M-6.92%29.86M-54.60%38.07M--27.49M
-Short-term investments 52.73%139.66M52.73%139.66M28.34%144.04M19.18%134.53M-7.93%85.37M-6.91%91.44M-6.91%91.44M150.83%112.23M--112.88M--92.72M
Other current assets -3.80%2.15M-3.80%2.15M-36.26%1.53M-21.78%1.82M-42.20%2.17M-48.57%2.23M-48.57%2.23M29.91%2.4M-29.48%2.33M--3.75M
Total current assets 40.05%181.63M40.05%181.63M30.79%188.98M18.97%182.36M-9.54%112.14M-1.82%129.69M-1.82%129.69M83.66%144.49M75.86%153.28M--123.96M
Non current assets
Net PPE 1.48%8.03M1.48%8.03M36.81%8.47M17.05%7.44M15.86%7.61M15.24%7.91M15.24%7.91M-12.94%6.19M-11.95%6.36M--6.57M
-Gross PPE 12.67%9.99M12.67%9.99M44.74%10.13M25.85%8.85M23.57%8.79M21.72%8.86M21.72%8.86M-5.51%7M-4.97%7.03M--7.12M
-Accumulated depreciation -105.23%-1.96M-105.23%-1.96M-105.58%-1.66M-108.90%-1.41M-116.51%-1.18M-127.62%-956K-127.62%-956K-173.56%-807K-276.54%-674K---545K
Investments and advances --5.09M--5.09M--15.39M--39.9M------0--0--0--0--39.28M
Non current deferred assets 556.18%1.65M556.18%1.65M--468K--468K--348K--251K--251K------------
Other non current assets -52.17%198K-52.17%198K234.55%1.38M3.19%421K7.47%417K6.70%414K6.70%414K5.93%411K5.15%408K--388K
Total non current assets 74.49%14.96M74.49%14.96M289.39%25.7M612.68%48.23M-81.88%8.38M-82.55%8.57M-82.55%8.57M-27.00%6.6M-13.62%6.77M--46.23M
Total assets 42.18%196.59M42.18%196.59M42.09%214.68M44.07%230.59M-29.19%120.52M-23.71%138.27M-23.71%138.27M72.26%151.09M68.48%160.05M--170.2M
Liabilities
Current liabilities
Payables -84.98%758K-84.98%758K0.13%1.51M-0.47%1.26M49.64%2.06M458.41%5.05M458.41%5.05M-23.89%1.5M-33.39%1.27M--1.37M
-accounts payable -84.98%758K-84.98%758K0.13%1.51M-0.47%1.26M49.64%2.06M458.41%5.05M458.41%5.05M-23.89%1.5M-33.39%1.27M--1.37M
Current accrued expenses 182.63%9.94M182.63%9.94M105.36%8.24M107.77%6.1M91.47%4.13M63.25%3.52M63.25%3.52M67.24%4.01M204.78%2.94M--2.16M
Current debt and capital lease obligation 20.52%1.06M20.52%1.06M34.02%1.04M29.88%978K27.57%944K20.80%877K20.80%877K8.23%776K6.66%753K--740K
-Current capital lease obligation 20.52%1.06M20.52%1.06M34.02%1.04M29.88%978K27.57%944K20.80%877K20.80%877K8.23%776K6.66%753K--740K
Current deferred liabilities ------------------------------0--0--0
Current liabilities 29.40%17.21M29.40%17.21M59.36%14.82M60.81%11.28M59.12%9.04M104.16%13.3M104.16%13.3M45.50%9.3M57.61%7.02M--5.68M
Non current liabilities
Long term debt and capital lease obligation -31.30%2.59M-31.30%2.59M-18.41%2.97M-15.72%3.24M-13.47%3.5M-11.05%3.77M-11.05%3.77M-17.56%3.64M-16.38%3.85M--4.05M
-Long term capital lease obligation -31.30%2.59M-31.30%2.59M-18.41%2.97M-15.72%3.24M-13.47%3.5M-11.05%3.77M-11.05%3.77M-17.56%3.64M-16.38%3.85M--4.05M
Total non current liabilities -31.30%2.59M-31.30%2.59M-18.41%2.97M-15.72%3.24M-13.47%3.5M-11.05%3.77M-11.05%3.77M-97.13%3.64M-96.97%3.85M--4.05M
Total liabilities 16.00%19.8M16.00%19.8M37.46%17.79M33.70%14.53M28.93%12.54M58.78%17.07M58.78%17.07M-90.29%12.94M-91.74%10.87M--9.73M
Shareholders'equity
Share capital 34.78%31K34.78%31K40.91%31K40.91%31K4.55%23K4.55%23K4.55%23K1,000.00%22K1,000.00%22K--22K
-common stock 34.78%31K34.78%31K40.91%31K40.91%31K4.55%23K4.55%23K4.55%23K1,000.00%22K1,000.00%22K--22K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -69.19%-196.98M-69.19%-196.98M-79.22%-174.15M-83.43%-151.7M-93.21%-132.91M-107.77%-116.42M-107.77%-116.42M-106.29%-97.17M-118.18%-82.7M---68.79M
Paid-in capital 57.06%373.28M57.06%373.28M57.14%370.22M58.31%367.75M5.11%240.93M4.90%237.68M4.90%237.68M14,461.00%235.6M17,404.97%232.29M--229.23M
Gains losses not affecting retained earnings 638.55%447K638.55%447K358.94%782K95.55%-19K-877.78%-70K12.63%-83K12.63%-83K-127.07%-302K---427K--9K
Total stockholders'equity 45.87%176.79M45.87%176.79M42.52%196.89M44.83%216.06M-32.71%107.98M-28.91%121.2M-28.91%121.2M402.85%138.15M507.87%149.18M--160.47M
Total equity 45.87%176.79M45.87%176.79M42.52%196.89M44.83%216.06M-32.71%107.98M-28.91%121.2M-28.91%121.2M402.85%138.15M507.87%149.18M--160.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
-0.07%
Vale SA
VALE
-1.28%
NVIDIA
NVDA
-1.58%
Ecopetrol
EC
-1.64%
Taylor Morrison Home
TMHC
-2.11%

Unlock the Full List